LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 JW-7-24-1
0.12
uM
LJP6
 0.7916 0.0051 0.6529 0.0200
SK-BR-3 Lapatinib
0.12
uM
LJP6
 0.3933 0.0191 -0.0081 0.0368
SK-BR-3 LDN-193189
0.12
uM
LJP5
 1.0481 0.0486 1.0845 0.0793
SK-BR-3 Linifanib
0.12
uM
LJP6
 1.0349 0.0198 1.0545 0.0311
SK-BR-3 Linsitinib
0.12
uM
LJP5
 0.8642 0.0368 0.7718 0.0638
SK-BR-3 Mitoxantrone
0.12
uM
LJP5
 0.3758 0.0289 -0.0418 0.0890
SK-BR-3 Mitoxantrone
0.12
uM
LJP6
 0.3427 0.0407 -0.0994 0.1177
SK-BR-3 MK2206
0.12
uM
LJP6
 0.7337 0.0375 0.5599 0.0516
SK-BR-3 Neratinib
0.12
uM
LJP5
 0.3371 0.0282 -0.1093 0.1086
SK-BR-3 Nilotinib
0.12
uM
LJP5
 1.1007 0.0177 1.1677 0.0313
SK-BR-3 Nintedanib
0.12
uM
LJP6
 0.9886 0.0192 0.9822 0.0306
SK-BR-3 NU7441
0.12
uM
LJP5
 0.9855 0.0230 0.9791 0.0351
SK-BR-3 Dactolisib
0.12
uM
LJP5
 0.4215 0.0312 0.0384 0.0580
SK-BR-3 NVP-TAE684
0.12
uM
LJP6
 0.8561 0.0706 0.7497 0.1219
SK-BR-3 Palbociclib
0.12
uM
LJP6
 0.7806 0.0257 0.6382 0.0263
SK-BR-3 PD0325901
0.12
uM
LJP5
 0.9281 0.0083 0.8807 0.0134
SK-BR-3 PD0325901
0.12
uM
LJP6
 0.9367 0.0217 0.8979 0.0292
SK-BR-3 PD173074
0.12
uM
LJP6
 1.0580 0.0521 1.0968 0.0867
SK-BR-3 PD184352
0.12
uM
LJP5
 1.0563 0.0167 1.0926 0.0257
SK-BR-3 Pelitinib
0.12
uM
LJP5
 0.5827 0.1052 0.3251 0.1337
SK-BR-3 PF431396
0.12
uM
LJP5
 0.7837 0.0330 0.6433 0.0484
SK-BR-3 PF477736
0.12
uM
LJP5
 0.3510 0.0517 -0.0822 0.1127
SK-BR-3 PF562271
0.12
uM
LJP6
 0.9619 0.0354 0.9421 0.0527
SK-BR-3 PHA-665752
0.12
uM
LJP5
 1.0617 0.0227 1.1036 0.0383
SK-BR-3 PHA-793887
0.12
uM
LJP6
 0.4470 0.0140 0.0803 0.0393